The role and mechanism of CRL4 E3 ubiquitin ligase in cancer and its potential therapy implications.
The role and mechanism of CRL4 E3 ubiquitin ligase in cancer and its potential therapy implications.
复制标题
CRL4 E3 泛素连接酶在癌症中的作用和机制及其潜在的治疗意义。
DOI:
10.18632/oncotarget.6052
复制
发表时间:
2015-12-15
期刊:
影响因子:
--
通讯作者:
Ren X
中科院分区:
文献类型:
--
作者:
Sang Y;Yan F;Ren X
CRLs (Cullin-RING E3 ubiquitin ligases) are the largest E3 ligase family in eukaryotes, which ubiquitinate a wide range of substrates involved in cell cycle regulation, signal transduction, transcriptional regulation, DNA damage response, genomic integrity, tumor suppression and embryonic development. CRL4 E3 ubiquitin ligase, as one member of CRLs family, consists of a RING finger domain protein, cullin4 (CUL4) scaffold protein and DDB1–CUL4 associated substrate receptors. The CUL4 subfamily includes two members, CUL4A and CUL4B, which share extensively sequence identity and functional redundancy. Aberrant expression of CUL4 has been found in a majority of tumors. Given the significance of CUL4 in cancer, understanding its detailed aspects of pathogenesis of human malignancy would have significant value for the treatment of cancer. Here, the work provides an overview to address the role of CRL4 E3 ubiquitin ligase in cancer development and progression, and discuss the possible mechanisms of CRL4 ligase involving in many cellular processes associated with tumor. Finally, we discuss its potential value in cancer therapy.